FGF2 and neoplasm: However, various studies showed that inhibition of VEGF signaling upregulated components of the bypass pathways such as fibroblast growth factors 2 (FGF2), angiopoietin (2ANGPT2) and HIF family members, which resulted in anti-angiogenesis resistance in tumor cells (174).